This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Currently available therapies for Hunter syndrome don’t cross the blood-brain ba...
CMS recently issued a statement saying that it’s continuing the Medicare Drug Pr...
Bain Capital’s buyout of Mitsubishi Tanabe Pharma brings a company with a drug p...